Cochrane Abstracts
Elective versus symptomatic intravenous antibiotic therapy for cystic fibrosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Elective Versus Symptomatic Intravenous Antibiotic Therapy for Cystic Fibrosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434363/all/Elective_versus_symptomatic_intravenous_antibiotic_therapy_for_cystic_fibrosis.
Elective versus symptomatic intravenous antibiotic therapy for cystic fibrosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434363/all/Elective_versus_symptomatic_intravenous_antibiotic_therapy_for_cystic_fibrosis. Accessed January 21, 2025.
Elective versus symptomatic intravenous antibiotic therapy for cystic fibrosis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434363/all/Elective_versus_symptomatic_intravenous_antibiotic_therapy_for_cystic_fibrosis
Elective Versus Symptomatic Intravenous Antibiotic Therapy for Cystic Fibrosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434363/all/Elective_versus_symptomatic_intravenous_antibiotic_therapy_for_cystic_fibrosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Elective versus symptomatic intravenous antibiotic therapy for cystic fibrosis
ID - 434363
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434363/all/Elective_versus_symptomatic_intravenous_antibiotic_therapy_for_cystic_fibrosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
